Market valuations reflect strong optimism for an AI-driven productivity boom, but multiple scenarios are plausible. Read the ...
AnaptysBio has spun off its biopharma pipeline into First Tracks Biotherapeutics, shifting to a royalty-focused, virtual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results